Author Topic: Zinbryta (daclizumab) pulled from market due to safety concerns  (Read 277 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9821
  • MS diagnosed 1980
  • Location: Pacific Northwest

The study concerns 7 patients, 2 of whom died. From Multiple Sclerosis Journal (January 19, 2019)--"Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis."

https://journals.sagepub.com/doi/abs/10.1177/1352458518819098
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
90 Views
Last post May 31, 2016, 01:48:51 pm
by agate
0 Replies
202 Views
Last post July 11, 2017, 03:01:11 pm
by agate
0 Replies
35 Views
Last post May 17, 2021, 09:17:00 pm
by agate
0 Replies
14 Views
Last post February 19, 2023, 09:43:41 pm
by agate
0 Replies
5 Views
Last post February 01, 2024, 10:13:30 am
by agate